glp 1 drugs and menopause Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 The GLP-1/GIP dual-receptor agonist tirzepatide

This combination creates a comprehensive approach to cellular health, addressing both energy production and detoxification needs

doi: 10.3233/JAD-191068 9 MiaoYGuoDLiWZhongY

Liraglutide 3.0 mg (Saxenda, Novo Nordisk, Bagsvaerd, Denmark), 2018

The latter includes five repurposed drugs (relugolix, goserelin, elagolix, triptorelin, leuprorelin depot) and two new chemical entities or combinations that have been developed specifically for uterine fibroids: relugolix combined tablet and linzagolix

Among them, oxidative damage to the autonomic nervous system due to iron accumulation associated with diabetes may be due to changes in the NRF2-GPX4 pathway in ferroptosis (113, 114), the transcription factor that regulates SLC7A11 (51) can effectively prevent oxidative damage in various pathological conditions upon NRF2 activation (115, 116)

& Handa, J